World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
113
Citations
43277
World Ranking
436
National Ranking
19

Medicine

D-Index
114
Citations
44085
World Ranking
4778
National Ranking
263

Reinhard Hohlfeld publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Reinhard Hohlfeld sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 487 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Reinhard Hohlfeld D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Reinhard Hohlfeld sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 113 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2005 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Neurosciences

Overview

Reinhard Hohlfeld is affiliated with Ludwig-Maximilians-Universität München in Germany and specializes primarily in Medicine, focusing on multiple research fields related to pathology, immunology, and neurology. The scientist's work covers a range of subfields including Pathology and Forensic Medicine, Molecular Biology, Immunology, Neurology, and Oncology.

The main topics of their research reflect an emphasis on immunological mechanisms and neurological diseases, particularly multiple sclerosis. These topics include:

  • Multiple Sclerosis Research Studies
  • T-cell and B-cell Immunology
  • Gut microbiota and health
  • Peripheral Neuropathies and Disorders
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Mycobacterium research and diagnosis
  • Immunotherapy and Immune Responses

Reinhard Hohlfeld has coauthored frequently with several researchers, notably:

  • Lisa Ann Gerdes
  • Tania Kümpfel
  • Eduardo Beltrán
  • Xavier Montalbán
  • Andrea Flierl-Hecht

The scientist's publication record includes appearances in prominent venues such as:

  • Neurology
  • Proceedings of the National Academy of Sciences
  • Brain
  • Multiple Sclerosis Journal
  • Annals of Neurology

Selected research publications by Reinhard Hohlfeld include:

  • "Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course," 2022, Cell
  • "Role of B Cells in Multiple Sclerosis and Related Disorders," 2020, Annals of Neurology
  • "Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study," 2021, JAMA Neurology
  • "The role of the gut microbiota in multiple sclerosis," 2022, Nature Reviews Neurology
  • "Twin study reveals non-heritable immune perturbations in multiple sclerosis," 2022, Nature

In 2005, Reinhard Hohlfeld received recognition from the German National Academy of Sciences Leopoldina for contributions to Neurosciences.

Best Publications

  • A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

    Ludwig Kappos;Ernst Wilhelm Radue;Paul O'Connor;Chris Polman

  • Polymyositis and Dermatomyositis

    Marinos C Dalakas;Reinhard Hohlfeld

  • Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction

    Holger Babbe;Axel Roers;Ari Waisman;Hans Lassmann

  • Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

    Martin Kerschensteiner;Eike Gallmeier;Lüder Behrens;Vivian Vargas Leal

  • Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.

    Kerstin Berer;Lisa Ann Gerdes;Egle Cekanaviciute;Xiaoming Jia

  • BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

    Markus Krumbholz;Diethilde Theil;Tobias Derfuss;Andreas Rosenwald

  • MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

    Andreas Junker;Markus Krumbholz;Sylvia Eisele;Hema Mohan

  • Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.

    Markus Krumbholz;Diethilde Theil;Sabine Cepok;Bernhard Hemmer

  • BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?

    Christine Stadelmann;Martin Kerschensteiner;Thomas Misgeld;Wolfgang Brück

  • Multiple sclerosis: Brain-infiltrating CD8(+) T cells persist as clonal expansions in the cerebrospinal fluid and blood

    Christian Skulina;Stephan Schmidt;Klaus Dornmair;Holger Babbe

  • Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.

    R Hohlfeld

  • Neurofascin as a novel target for autoantibody-mediated axonal injury

    Emily K. Mathey;Tobias Derfuss;Maria K. Storch;Kieran R. Williams

  • The neuroprotective effect of inflammation: Implications for the therapy of multiple sclerosis.

    Reinhard Hohlfeld;Martin Kerschensteiner;Christine Stadelmann;Hans Lassmann

  • Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    Ludwig Kappos;David Bates;Gilles Edan;Mefkûre Eraksoy

  • B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation.

    Edgar Meinl;Markus Krumbholz;Reinhard Hohlfeld

  • Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica

    Sven Jarius;Friedemann Paul;Diego Franciotta;Patrick Waters

  • Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

    Unknown

  • Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

    Oliver Neuhaus;Cinthia Farina;Alexander Yassouridis;Heinz Wiendl

  • Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab

    H. L. Pellkofer;M. Krumbholz;A. Berthele;B. Hemmer

  • Neurotrophic cross-talk between the nervous and immune systems: Implications for neurological diseases

    Martin Kerschensteiner;Christine Stadelmann;Georg Dechant;Hartmut Wekerle

  • Glatiramer acetate‐specific T‐helper 1‐ and 2‐type cell lines produce BDNF: implications for multiple sclerosis therapy

    Tjalf Ziemssen;Tania Kümpfel;Wolfgang E. F. Klinkert;Oliver Neuhaus

Frequent Co-Authors

Edgar Meinl
Edgar Meinl Ludwig-Maximilians-Universität München
Hartmut Wekerle
Hartmut Wekerle Max Planck Society
Heinz Wiendl
Heinz Wiendl University of Münster
Klaus Dornmair
Klaus Dornmair Ludwig-Maximilians-Universität München
Ralf Gold
Ralf Gold Ruhr University Bochum
Frauke Zipp
Frauke Zipp Johannes Gutenberg University of Mainz
Frank Weber
Frank Weber HEMAP AG
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Klaus V. Toyka
Klaus V. Toyka University of Würzburg
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, branching into related healthcare fields can expand career opportunities. Online programs like the best pmhnp programs offer specialized training in psychiatric mental health nursing, which often includes critical clinical placements to build practical experience.

Cost is a significant consideration for many aspiring practitioners. Fortunately, the cheap psych np programs provide affordable options without sacrificing quality education. These programs can open doors to careers in mental health, a field closely linked to immunology in areas like neuroimmunology and psychoneuroimmunology.

Career advancement also depends on choosing the right specialization. Data from the highest paid dnp specialties show that certain Nurse Practitioner roles offer significantly higher salaries, reflecting demand and expertise required.

Lastly, transitioning careers is achievable through targeted certifications. For instance, nurses can move from a Family Nurse Practitioner role to a more specialized area by following guidance such as outlined in fnp to acute care certification. This pathway allows nurses to engage with acute and critical care patient populations, a useful skillset for immunology-related healthcare.

Best Scientists Citing Reinhard Hohlfeld

Trending Scientists

Recently Published Articles